Jacob van Naarden - 09 Feb 2026 Form 4 Insider Report for ELI LILLY & Co (LLY)

Role
EVP,Pres LLY Oncology&HdCorpBD
Signature
/s/ Jonathan Groff for Jacob Van Naarden, pursuant to authorization on file
Issuer symbol
LLY
Transactions as of
09 Feb 2026
Net transactions value
+$5,083,247
Form type
4
Filing time
11 Feb 2026, 16:25:13 UTC
Previous filing
03 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Van Naarden Jacob EVP,Pres LLY Oncology&HdCorpBD LILLY CORPORATE CENTER, INDIANAPOLIS /s/ Jonathan Groff for Jacob Van Naarden, pursuant to authorization on file 11 Feb 2026 0001661254

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LLY Common Stock Award $5,083,247 +4,866 +22% $1044.67 26,626 09 Feb 2026 Direct
holding LLY Common Stock 4,342 09 Feb 2026 Van Naarden Family Trust F1
holding LLY Common Stock 5,302 09 Feb 2026 By SLAT F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
F2 On February 5, 2026, the Reporting Person's spouse transferred 5,302 shares of Eli Lilly and Company common stock to a spousal lifetime access trust, of which the Reporting Person is the trustee and a beneficiary. The transfer included 1,000 spouse-held shares previously reported as directly held due to an administrative error.